US Stock MarketDetailed Quotes

ANVS Annovis Bio

Watchlist
  • 7.290
  • +0.210+2.97%
Close May 24 16:00 ET
  • 7.400
  • +0.110+1.51%
Post 19:52 ET
81.44MMarket Cap-1265P/E (TTM)

Annovis Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.51%-7.03M
-130.85%-39.97M
-159.46%-9.36M
-135.00%-9.37M
-43.49%-9.61M
-284.75%-11.63M
-89.58%-17.31M
-104.00%-3.61M
-128.70%-3.99M
-112.89%-6.69M
Net income from continuing operations
89.04%-1.07M
-121.90%-56.2M
-187.51%-22.21M
-128.80%-14.72M
-60.66%-9.54M
-86.03%-9.74M
-74.83%-25.33M
-30.63%-7.73M
-125.82%-6.43M
-135.14%-5.94M
Operating gains losses
---6.7M
--11.84M
----
----
----
----
----
----
----
----
Change In working capital
110.73%368.12K
79.89%-228.6K
-95.15%128.83K
5,210.59%4.71M
38.37%-1.64M
-180.65%-3.43M
-272.95%-1.14M
901.10%2.66M
-72.16%88.78K
-323.91%-2.66M
-Change in prepaid assets
80.53%-222.78K
143.54%3.19M
76.71%-585.38K
383.18%3.22M
166.17%1.7M
-2.78%-1.14M
-2,606.51%-7.33M
-1,988.84%-2.51M
-1,580.63%-1.14M
-2,945.69%-2.56M
-Change in payables and accrued expense
125.83%590.91K
-155.22%-3.42M
-86.19%714.21K
21.50%1.49M
-3,314.72%-3.34M
-1,990.87%-2.29M
567.15%6.19M
1,240.20%5.17M
407.12%1.23M
86.39%-97.74K
Cash from discontinued investing activities
Operating cash flow
39.51%-7.03M
-130.85%-39.97M
-159.46%-9.36M
-135.00%-9.37M
-43.49%-9.61M
-284.75%-11.63M
-89.58%-17.31M
-104.00%-3.61M
-128.70%-3.99M
-112.89%-6.69M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
59,675.25%4.42M
375,888.10%17.34M
8.76M
0
8.57M
60.11%7.39K
-99.99%4.61K
0
0
0
Net common stock issuance
--3.88M
--16.89M
--8.31M
--0
--8.57M
--0
--0
--0
--0
----
Proceeds from stock option exercised by employees
7,211.13%540K
9,836.81%458.39K
--450K
--0
--1K
60.11%7.39K
-95.15%4.61K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
59,675.25%4.42M
375,888.10%17.34M
--8.76M
--0
--8.57M
60.11%7.39K
-99.99%4.61K
--0
--0
--0
Net cash flow
Beginning cash position
-79.72%5.75M
-37.89%28.38M
-80.13%6.35M
-56.29%15.72M
-60.72%16.76M
-37.89%28.38M
465.80%45.69M
-32.60%31.99M
-26.92%35.97M
661.56%42.67M
Current changes in cash
77.47%-2.62M
-30.71%-22.62M
83.37%-600.22K
-135.00%-9.37M
84.55%-1.03M
-285.09%-11.62M
-146.02%-17.31M
-104.00%-3.61M
-125.41%-3.99M
-115.35%-6.69M
End cash Position
-81.28%3.14M
-79.72%5.75M
-79.72%5.75M
-80.13%6.35M
-56.29%15.72M
-60.72%16.76M
-37.89%28.38M
-37.89%28.38M
-32.60%31.99M
-26.92%35.97M
Free cash flow
39.51%-7.03M
-130.85%-39.97M
-159.46%-9.36M
-135.00%-9.37M
-43.49%-9.61M
-284.75%-11.63M
-89.58%-17.31M
-104.00%-3.61M
-128.70%-3.99M
-112.89%-6.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.51%-7.03M-130.85%-39.97M-159.46%-9.36M-135.00%-9.37M-43.49%-9.61M-284.75%-11.63M-89.58%-17.31M-104.00%-3.61M-128.70%-3.99M-112.89%-6.69M
Net income from continuing operations 89.04%-1.07M-121.90%-56.2M-187.51%-22.21M-128.80%-14.72M-60.66%-9.54M-86.03%-9.74M-74.83%-25.33M-30.63%-7.73M-125.82%-6.43M-135.14%-5.94M
Operating gains losses ---6.7M--11.84M--------------------------------
Change In working capital 110.73%368.12K79.89%-228.6K-95.15%128.83K5,210.59%4.71M38.37%-1.64M-180.65%-3.43M-272.95%-1.14M901.10%2.66M-72.16%88.78K-323.91%-2.66M
-Change in prepaid assets 80.53%-222.78K143.54%3.19M76.71%-585.38K383.18%3.22M166.17%1.7M-2.78%-1.14M-2,606.51%-7.33M-1,988.84%-2.51M-1,580.63%-1.14M-2,945.69%-2.56M
-Change in payables and accrued expense 125.83%590.91K-155.22%-3.42M-86.19%714.21K21.50%1.49M-3,314.72%-3.34M-1,990.87%-2.29M567.15%6.19M1,240.20%5.17M407.12%1.23M86.39%-97.74K
Cash from discontinued investing activities
Operating cash flow 39.51%-7.03M-130.85%-39.97M-159.46%-9.36M-135.00%-9.37M-43.49%-9.61M-284.75%-11.63M-89.58%-17.31M-104.00%-3.61M-128.70%-3.99M-112.89%-6.69M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 59,675.25%4.42M375,888.10%17.34M8.76M08.57M60.11%7.39K-99.99%4.61K000
Net common stock issuance --3.88M--16.89M--8.31M--0--8.57M--0--0--0--0----
Proceeds from stock option exercised by employees 7,211.13%540K9,836.81%458.39K--450K--0--1K60.11%7.39K-95.15%4.61K--0--0--0
Cash from discontinued financing activities
Financing cash flow 59,675.25%4.42M375,888.10%17.34M--8.76M--0--8.57M60.11%7.39K-99.99%4.61K--0--0--0
Net cash flow
Beginning cash position -79.72%5.75M-37.89%28.38M-80.13%6.35M-56.29%15.72M-60.72%16.76M-37.89%28.38M465.80%45.69M-32.60%31.99M-26.92%35.97M661.56%42.67M
Current changes in cash 77.47%-2.62M-30.71%-22.62M83.37%-600.22K-135.00%-9.37M84.55%-1.03M-285.09%-11.62M-146.02%-17.31M-104.00%-3.61M-125.41%-3.99M-115.35%-6.69M
End cash Position -81.28%3.14M-79.72%5.75M-79.72%5.75M-80.13%6.35M-56.29%15.72M-60.72%16.76M-37.89%28.38M-37.89%28.38M-32.60%31.99M-26.92%35.97M
Free cash flow 39.51%-7.03M-130.85%-39.97M-159.46%-9.36M-135.00%-9.37M-43.49%-9.61M-284.75%-11.63M-89.58%-17.31M-104.00%-3.61M-128.70%-3.99M-112.89%-6.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg